← Open Payments lookup

ERIN CASSIDY: Open Payments

NPI 1043401201 · ROSEBURG, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$694 in 57 payments from 13 companies in 2025. Trend: 2023 $232 · 2024 $424 · 2025 $694

Food & beverage: $694
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation20$205
PFIZER INC.18$140
AstraZeneca Pharmaceuticals LP5$76
Actelion Pharmaceuticals US, Inc.1$40
E.R. Squibb & Sons, L.L.C.2$38
Novo Nordisk Inc2$34
Amgen Inc.2$34
Alnylam Pharmaceuticals Inc.2$32
Edwards Lifesciences Corporation1$22
Merck Sharp & Dohme LLC1$21

Products named: LEQVIO, ELIQUIS, LOKELMA, OPSYNVI, Wegovy, REPATHA, AMVUTTRA, CAMZYOS.

Industry payments across OR — which companies pay providers there.